To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.

119-hr1492 — To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.. Sponsored by Rep. Murphy, Gregory F. [R-NC-3]. Introduced 2025-02-21. House bill. 119th Congress. Latest action: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

119-hr1492 119th Congress House
XML

Bill Activity

House
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on National Parks.
Subcommittee Hearings Held.
Subcommittee on National Parks Discharged.
Reported (Amended) by the Committee on Resources. H. Rept. 109-142.
Received in the Senate and Read twice and referred to the Committee on Energy and Natural Resources.
Committee on Energy and Natural Resources Subcommittee on National Parks. Hearings held.
Committee on Energy and Natural Resources. Ordered to be reported with amendments favorably.
Committee on Energy and Natural Resources. Reported by Senator Domenici with amendments. With written report No. 109-314.
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H10321)
Senate
Passed Senate with amendments by Unanimous Consent. (consideration: CR S11105; text as passed Senate: CR S11105)
President
Presented to President.
Became Public Law No: 109-441.
Sponsor
Rep. Murphy, Gregory F. [R-NC-3] (R), NC
Introduced
2025-02-21
Committees
Ways and Means Committee; Energy and Commerce Committee
Subjects
Health care costs and insurance; Medicare; Prescription drugs
Latest Action
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

No roll-call vote data available for this bill.

Explore This Bill

Investigate this bill → AI summary, roll-call breakdown, and full bill analysis